Work

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

Year: 2013

Type: article

Study design: Clinical Trial

Source: Bone Marrow Transplantation

DOI: 10.1038/bmt.2013.175

Authors: S K Kumar, J Mikhael, B LaPlant, M Q Lacy, F K Buadi, D Dingli, M A Gertz, K Laumann, T Miceli, M Mahlman, L P Bergsagel, S R Hayman, C Reeder, A K Stewart, A Dispenzieri, D A Gastineau, J L Winters

Institutions: Mayo Clinic, Mayo Clinic in Arizona

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Celgene, Mayo Foundation for Medical Education and Research, Amicus Therapeutics, National Cancer Institute

Awards: G5331956034, Mayo Clinic Comprehensive Cancer Center Support Grant, Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic

OpenAlex ID: W1972199717

FWCI: 1.486

Cites: 32

Cited by: 23

Related to: 10